Nervous System Diseases clinical trials

Explore recruiting nervous system diseases clinical trials.

Recruiting nervous system diseases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nervous System Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis

Sweden, Croatia, Norway, Slovakia, France, Lithuania +17 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis

Denmark, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Exploration of the pathophysiology of cluster headache (AVF) in PET-MRI using [18F]F13640 F13640-AVF

France

Therapeutic exploratory (Phase II) EU CTIS Study details

I5T-MC-AACQ: Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults with Early Symptomatic Alzheimer’s Disease

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

I5T-MC-AACO: Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease

Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cognitive brain circuits and the spread of tau in vivo in humans.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Nervous System Diseases trials by city

Nervous System Diseases clinical trials

Recruiting nervous system diseases studies right now

Y-4 to Treat the Postherpetic Neuralgia

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

taVNS Combined With TENS on Motor Function in Stroke

Visual Influences on Vestibular Adaptation

Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy

A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities

Aspirational Rehabilitation Coaching for Holistic Health (ARCH): A Pilot Pre-Post Experimental Study

Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

Telenutrition for Individuals With SCI

Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

Q702 for the Treatment of Patients With Hematologic Malignancies

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Also recruiting in Europe

An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis

An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis

Exploration of the pathophysiology of cluster headache (AVF) in PET-MRI using [18F]F13640 F13640-AVF

I5T-MC-AACQ: Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults with Early Symptomatic Alzheimer’s Disease

I5T-MC-AACO: Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease

Cognitive brain circuits and the spread of tau in vivo in humans.

Nervous System Diseases trials by city

Other conditions